Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: A north central cancer treatment group review of 3811 patients, n0144

Clinical Colorectal Cancer

Volumn 8, Issue 2, 2009, Pages 88-93

  Dy, Grace K ^a   Hobday, Timothy J ^b   Nelson, Garth ^b   Windschitl, Harold E ^c   O'Connell, Michael J ^d   Alberts, Steven R ^b   Goldberg, Richard M ^e   Nikcevich, Daniel A ^f   Sargent, Daniel J ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c CentraCare Clinic   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f Duluth CCOP   (United States)

Author keywords

5 fluorouracil; Disease site; Leucovorin; Liver metastasis

Indexed keywords

6 DIAZO 5 OXONORLEUCINE; ALANOSINE; ANTINEOPLASTIC AGENT; BISANTRENE; CARMUSTINE; CHLOROZOTOCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DIAZIQUONE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GALACTITOL; HYCANTHONE; IFOSFAMIDE; INDICINE N OXIDE; MAYTANSINE; NSC 132313; NSC 14982; PIRAZOFURIN; PLATINUM; RAZOXANE; SEMUSTINE; SPARFOSIC ACID; STREPTOZOCIN; TEGAFUR; TIOGUANINE; TRIAZINATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CANCER SURVIVOR; COLORECTAL CANCER; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERFORMANCE; PROSPECTIVE STUDY; SEX RATIO; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 68149145782     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2009.n.014     Document Type: Review

References (30)

1. Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet1998; 352:1413-8.
2. Scheithauer W, Rosen H, Kornek GV, et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ1993; 306:752-5.
3. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomised trial. J Clin Oncol1992; 10:904-11.
4. Glimelius B, Hoffman K, Graf W, et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol1995; 6:267-74.
5. Advanced colorectal Cancer Meta-Analysis Project, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol1992; 10:896-903.
6. The Meta-analysis Group of Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol1998; 16:301-8.
7. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg1995; 19:59-71.
8. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. Cancer1996; 77:1254-62.
9. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer1993; 71:4252-66.
10. Goya T, Miyazawa N, Kondo H, et al. Surgical resection of pulmonary metastases from colorectal cancer. 10-year follow-up. Cancer1989; 64:1418-21.
11. Yano T, Hara N, Ichinose Y, et al. Results of pulmonary resection of metastatic colorectal cancer and its application. J Thorac Cardiovasc Surg1993; 106:875-9.
12. McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg1992; 53:780-6.
13. Gough DB, Donohue JH, Trastek VA, et al. Resection of hepatic and pulmonary metastases in patients with colorectal cancer. Br J Surg1994; 81:94-6.
14. Ambiru S, Miyazaki M, Ito H, et al. Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer2000; 82:274-8.
15. Massacesi C, Norman A, Price T, et al. A clinical nomogram for predicting longterm survival in advanced colorectal cancer. Eur J Cancer2000; 36:2044-52.
16. American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society; 2007:2.
17. Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol1997; 65:284-97.
18. Friberg S. The 5-year cure rate: Yet another myth. J Surg Oncol1997; 65:73-5.
19. Perez N, Tournigand C, Mabro M, et al. Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy. Rev Med Int2004; 25:124-8.
20. Dy GK, Krook JE, Green EM, et al. Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741. J Clin Oncol2007; 25:3469-74.
21. Iwashita I, Ueyama T, Iwashita A, et al. Natural history of colorectal carcinoma: can the tumor volume doubling time be predicted by radiologic findings or immunohistochemical variables? J Surg Oncol1998; 68:215-24.
22. Gray BN. Colorectal cancer: the natural history of disseminated disease-a review. 23. Aust N Z J Surg1980; 50:643-6.
23. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg1984; 199:502-8.
24. Janssen-Heijnen MLG, Houterman S, Lemmens VEPP, et al. Prognosis for long term survivors of cancer. Ann Oncol2007; 18:1403-13.
25. Mattioli R, Lippe P, Massacesi C, et al. Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicenter phase II trial. Anticancer Res2004; 24(5B):3257-61.
26. Schneeweiss A, Hensel M, Sinn P, et al. Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose. Ann Oncol2002; 13:679-88.
27. Dillman Ro, Church C, Barth NM, et al. Long-term survival after continuous infusion interleukin-2. Cancer Biother Radiopharm1997; 12:243-8.
28. Greenberg PA, Hortobagyi GN, Smith TL, et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol1996; 14:2197-205.
29. Thiesse P, Ollivier L, Di Stefano-Louineau D, et al. Response rate accuracy in oncology trials: reasons for interobserver variability. J Clin Oncol1997; 15:3507-14.
30. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response and other comparison of time-to-event by outcome variables. J Clin Oncol2008; 26:3913-5.